Your browser doesn't support javascript.
loading
Lenalidomide maintenance after autologous haematopoietic stem-cell transplantation in mantle cell lymphoma: results of a Fondazione Italiana Linfomi (FIL) multicentre, randomised, phase 3 trial.
Ladetto, Marco; Cortelazzo, Sergio; Ferrero, Simone; Evangelista, Andrea; Mian, Michael; Tavarozzi, Rita; Zanni, Manuela; Cavallo, Federica; Di Rocco, Alice; Stefoni, Vittorio; Pagani, Chiara; Re, Alessandro; Chiappella, Annalisa; Balzarotti, Monica; Zilioli, Vittorio R; Gomes da Silva, Maria; Arcaini, Luca; Molinari, Anna L; Ballerini, Filippo; Ferreri, Andrés J M; Puccini, Benedetta; Benedetti, Fabio; Stefani, Piero M; Narni, Franco; Casaroli, Ivana; Stelitano, Caterina; Ciccone, Giovannino; Vitolo, Umberto; Martelli, Maurizio.
Afiliação
  • Ladetto M; Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy. Electronic address: marco.ladetto@ospedale.al.it.
  • Cortelazzo S; Unit of Oncology-Haematology, Humanitas Gavazzeni, Bergamo, Italy.
  • Ferrero S; Department of Molecular Biotechnologies and Health Sciences, Universitaria Città della Salute e della Scienza di Torino and Centre for Cancer Prevention Piemonte, Torino, Italy.
  • Evangelista A; Clinical Epidemiology, Universitaria Città della Salute e della Scienza di Torino and Centre for Cancer Prevention Piemonte, Torino, Italy.
  • Mian M; Department of Haematology and CBMT, Bolzano Hospital, Bolzano, Italy.
  • Tavarozzi R; Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.
  • Zanni M; Azienda Ospedaliera SS Antonio e Biagio e Cesare Arrigo, Alessandria, Italy.
  • Cavallo F; Department of Molecular Biotechnologies and Health Sciences, Universitaria Città della Salute e della Scienza di Torino and Centre for Cancer Prevention Piemonte, Torino, Italy.
  • Di Rocco A; Department of Translational and Precision Medicine, Sapienza University of Rome, Roma, Italy.
  • Stefoni V; Institute of Haematology L. e A. Seràgnoli, University of Bologna, Bologna, Italy.
  • Pagani C; Department of Haematology, ASST-Spedali Civili Hospital, Brescia, Italy.
  • Re A; Department of Haematology, ASST-Spedali Civili Hospital, Brescia, Italy.
  • Chiappella A; Azienda Ospedaliero, Universitaria Città della Salute e della Scienza di Torino and Centre for Cancer Prevention Piemonte, Torino, Italy.
  • Balzarotti M; Haematology Unit, Humanitas Clinical and Research Center - IRCCS - Rozzano, Milano, Italy.
  • Zilioli VR; Division of Haematology, ASST Grande Ospedale Metropolitano Niguarda, Milano, Italy.
  • Gomes da Silva M; Haematology Unit, Instituto Portugues de Oncologia de Lisboa Francisco Gentil, Lisbon, Portugal.
  • Arcaini L; Division of Haematology, Fondazione IRCCS Policlinico S Matteo and Department of Molecular Medicine, University of Pavia, Pavia, Italy.
  • Molinari AL; Department of Haematology, Infermi Hospital, Rimini, Italy.
  • Ballerini F; University of Genoa, Ospedale Policlinico San Martino, IRCCS per l'Oncologia, Genova, Italy.
  • Ferreri AJM; Lymphoma Unit, Department of Onco-Haematology, IRCCS San Raffaele Scientific Institute, Milano, Italy.
  • Puccini B; Department of Haematology, University of Florence, Firenze, Italy.
  • Benedetti F; Haematology University Division, Verona Hospital, Verona, Italy.
  • Stefani PM; SC di Ematologia - Presidio Ospedaliero Ca' Foncello, Treviso, Italy.
  • Narni F; Department of Medical and Surgical Sciences, Section of Haematology, University of Modena and Reggio Emilia, Azienda Ospedaliero Universitaria Policlinico, Modena, Italy.
  • Casaroli I; Haematology Unit, ASST Monza San Gerardo, Monza, Italy.
  • Stelitano C; Department of Haematology, Azienda Ospedaliera Bianchi Melacrino Morelli, Reggio Calabria, Italy.
  • Ciccone G; Clinical Epidemiology, Universitaria Città della Salute e della Scienza di Torino and Centre for Cancer Prevention Piemonte, Torino, Italy.
  • Vitolo U; Azienda Ospedaliero, Universitaria Città della Salute e della Scienza di Torino and Centre for Cancer Prevention Piemonte, Torino, Italy.
  • Martelli M; Department of Translational and Precision Medicine, Sapienza University of Rome, Roma, Italy.
Lancet Haematol ; 8(1): e34-e44, 2021 Jan.
Article em En | MEDLINE | ID: mdl-33357480
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Linfoma de Célula do Manto / Quimioterapia de Manutenção / Lenalidomida Tipo de estudo: Clinical_trials / Guideline Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Linfoma de Célula do Manto / Quimioterapia de Manutenção / Lenalidomida Tipo de estudo: Clinical_trials / Guideline Limite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article